Alto Neuroscience EPS ANRO

Diluted earnings per share by quarter and over the last twelve months, from 2023.

Alto Neuroscience's earnings per share was −$2.44 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.65.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.65	n/a	−$2.44
Q1 FY26	Mar 31, 2026	−$0.80	n/a	−$2.44
Q4 FY25	Dec 31, 2025	−$0.47	n/a	−$2.20
Q3 FY25	Sep 30, 2025	−$0.52	n/a	−$2.30
Q2 FY25	Jun 30, 2025	−$0.65	n/a	−$2.40
Q1 FY25	Mar 31, 2025	−$0.56	n/a	−$2.35
Q4 FY24	Dec 31, 2024	−$0.57	n/a	−$2.55
Q3 FY24	Sep 30, 2024	−$0.62	n/a	−$4.95
Q2 FY24	Jun 30, 2024	−$0.60	n/a	−$6.77
Q1 FY24	Mar 31, 2024	−$0.76	n/a	−$8.50
Q4 FY23	Dec 31, 2023	−$2.97	n/a	−$9.71
Q3 FY23	Sep 30, 2023	−$2.44	n/a	n/a

Companies in Drug Manufacturers - General nearest Alto Neuroscience's size, closest first, today.

Company	EPS, 12 months	Growth
ANROAlto Neuroscience	−$2.44
ABUSArbutus Biopharma	$0.78
COLLCollegium Pharmaceutical	$1.24	+19% a year
AMPHAmphastar Pharmaceuticals	$1.70	−36% a year
OMEROmeros	$1.52
CRMDCorMedix	$2.13	+184% a year
ZVRAZevra Therapeutics	$0.93
IRWDIronwood Pharmaceuticals	$0.77
PBYIPuma Biotechnology	$0.52	−47% a year
PCRXPacira BioSciences	$0.35
ANABAnaptysbio	$4.57
Peer median	$1.08